Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults

Inclusion Criteria: * BMI 27\~30 kg/m2 Exclusion Criteria: * Within the last 6 months, severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease(Angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignant diseases (however, although subjects have a history of cerebrovascular disease and heart disease, they can be included if their status are clinically stable) * Patients with uncontrolled hypertension (blood pressure greater than 160/100 mmHg) * Diabetic patients with poor glycemic control with a fasting blood glucose of 160 mg/dl or more * Those who are treated with hypothyroidism or hyperthyroidism * Creatinine levels: more than twice the normal upper limit * Aspartate transaminase (AST), Alanine transaminase (ALT) levels: more than twice the normal upper limit * Those complaining of severe gastrointestinal symptoms such as heartburn and indigestion * Drugs that affect weight within the last month (absorption inhibitors and Appetite suppressant, health food / supplements related to obesity improvement, psychiatric Drugs, beta blockers, diuretics, birth control pills, steroids, female hormones) If you are taking * Participated in the commercial obesity program within the last 3 months. * If you have participated or are planning to participate in another clinical trial within the past month If yes * Alcohol abuser * Smoking abstinence within 3 months * If they are pregnant or lactating or have a pregnancy plan during the clinical trial * Those with allergic reactions to the constituent food * Any person deemed inappropriate by the researcher for other reasons